Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model

Life Sciences

Volumn 77, Issue 21, 2005, Pages 2690-2702

  Gaofu, Qi ^a,b   Jun, Long ^a   Xiuyun, Zhao ^b   Wentao, Liu ^a   Jie, Wu ^a   Jingjing, Liu ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Asparaginase; Atherosclerosis; Cholesteryl ester transfer protein; Vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIBODY; ASPARAGINASE; B LYMPHOCYTE ANTIGEN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; IMMUNOLOGICAL ADJUVANT; LOW DENSITY LIPOPROTEIN; OVALBUMIN; RECOMBINANT ENZYME; RECOMBINANT VACCINE; T LYMPHOCYTE ANTIGEN; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HELPER CELL; HYPERPLASIA; IMMUNIZATION; NONHUMAN; RABBIT; VACCINATION;

ANIMALS; ANTIBODIES, BLOCKING; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY VESSELS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; KIDNEY; RABBITS; RECOMBINANT FUSION PROTEINS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

ORYCTOLAGUS CUNICULUS;

EID: 24344449633     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.037     Document Type: Article

References (29)

1. B.F. Asztalos, and E.J. Schaefer HDL in atherosclerosis: actor or bystander? Atherosclerosis 4 1 2003 21 29 (Suppl)
2. P.J. Barter CETP and atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 20 2000 2029 2031
3. P. Barter, and K.A. Rye Cholesteryl ester transfer protein: its role in plasma lipid transport Clinical and Experimental Pharmacology and Physiology 21 1994 663 672
4. P.J. Barter, H.B. Brewer, and M.J. Chapman Cholesteryl ester transfer protein a novel target for raising HDL and inhibiting atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 23 2002 160 167
5. M.E. Brousseau, E.J. Schaefer, and M.L. Wolfe Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol New England Journal of Medicine 350 2004 1505 1511
6. C. Bruce, R.A. Chouinard, and A.R. Tall Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport Annual Review of Nutrition 18 1998 297 330
7. G.S. Buchan, S.L. Young, E.A. Lockhart, and J. Wales Targeting early events in T cell activation to construct improved vaccines Molecular Immunology 37 2000 545 552
8. P.L. Canner, K.G. Berge, and N.K. Wenger Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin Journal of the American College of Cardiology 8 1986 1245 1255
9. R.W. Clark, T.A. Sutfin, and R.B. Ruggeri Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein Arteriosclerosis, Thrombosis, and Vascular Biology 24 2004 490
10. M.H. Davidson, K. Maki, and D. Umporowicz The safety and immunogenicity of a CETP vaccine in healthy adults Atherosclerosis 169 2003 113 120
11. P. Durrington HDL in risk prediction and its direct and indirect involvement in atherogenesis Atherosclerosis 3 4 2002 3 12 (Suppl)
12. C.B. Hesler, A.R. Tall, and T.L. Swenson Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma Journal of Biological Chemistry 263 1988 5020 5023
13. Z. Huang, A. Inazu, and A. Nohara Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia Clinical Science 103 2002 587 594
14. A. Inazu, and H. Mabuchi Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia Current Opinion in Investigational Drugs 4 2003 291 297
15. L. Jingjing, Y. Xue, and N. Agarwal Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor Investigative Ophthalmol & Visual Science 40 1999 752 759
16. J. Lubkowski, G.J. Palm, and G.L. Gillil Crystal structure and amino acid sequence of Wolinella succinogenes l-asparaginase European Journal of Biochemistry 241 1996 201 207
17. P. Mettens, and P. Monteyne Life-style vaccines British Medical Bulletin 62 2002 175 186
18. P. Parini, and L.L. Rudel Is there a need for cholesteryl ester transfer protein inhibition? Arteriosclerosis, Thrombosis, and Vascular Biology 23 2003 374 375
19. G.F. Qi, D. Mao, and J. Wu Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants Vaccine 22 2004 3187 3194
20. S. Rafii Vaccination against tumor neovascularization: promise and reality Cancer Cells 2 2002 429 431
21. C.W. Rittershaus, D.P. Miller, and L.J. Thomas Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 20 2000 2106 2112
22. M. Sugano, N. Makino, and S. Sawada Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits Journal of Biological Chemistry 273 1998 5033 5036
23. A.L. Swain, M. Jaskolski, and D. Housset Crystal structure of Escherichia coli l-asparaginase, an enzyme used in cancer therapy Proceedings of the National Academy of Sciences of the United States of America 90 1993 1474 1478
24. T.L. Swenson, R.W. Brocia, and A.R. Tall Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids Journal of Biological Chemistry 263 1988 5150 5157
25. T.L. Swenson, C.B. Hesler, and M.L. Brown Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope Journal of Biological Chemistry 264 1989 14318 14326
26. A.R. Tall Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies Journal of Internal Medicine 237 1995 5 12
27. R. Thau Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications Scandinavian Journal of Immunology 11 1992 127 130 (Suppl)
28. S. Wang, L. Deng, and R.W. Milne Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing monoclonal antibody and necessary for neutral lipid transfer activity Journal of Biological Chemistry 267 1992 17487 17490
29. Q.B. Xu Role of heat shock proteins in atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 22 2002 1547 1559